Cheryl Zimberlin

Investment Director

Gustav Mahlerplein 102
Toyo lto Building, 20th Floor
1082 MA Amsterdam
The Netherlands

Cheryl Zimberlin, PhD, joined Ventures in May 2016 and is currently an Principal in the Biotechnology team. Cheryl received her BSc. Hons. in Biology from the University of Utrecht, a MSc in Biotechnology from the University of Wageningen and a PhD in Oncology from the University of Amsterdam. Before joining M Ventures she had a successful academic career publishing in top-tier academic journals, including Nature. Cheryl is based in Amsterdam and has board presence on several healthcare portfolio companies.

Portfolio Companies

more about
Calypso Biotech
more about
Indi molecular
more about
Inthera
more about
Macrophage Pharma
more about
Multitude Therapeutics
more about
Outrun Therapeutics
more about
Rewind Therapeutics
more about
Vaximm